Working to Eradicate Gynecologic Cancers

Robert Schneider, PhD

Professor
New York University School of Medicine
Alexandria Life Sciences Building
3rd Floor
New York, NY
USA 10016

Papers:
506 Dual mTORC1/2 inhibitor INK128 potentiates sensitivity to carboplatin in a platinum resistant ovarian cancer cell line